Allocations
Immune Pharmaceuticals Inc has secured financings of up to USD21.5 million through two financing agreements. The first, with Hercules Technology Growth Capital, for a term loan of up to USD9.5 million. The second agreement, with mutual fund Discover Growth Fund, for the sale to Discover of newly created Series D Redeemable Convertible Preferred Stock for up to USD12 million in gross proceeds to the company.
Immune received USD13.5 million in gross proceeds: USD9.0 million from Discover and USD4.5 million from Hercules, following the execution of the two agreements. Immune expects to receive an additional USD3.0 million from Discover upon an
Behalf, the payments platform targeted at small and mid-sized businesses, has secured a Series B equity round and credit facility totalling USD119 million.
MissionOG, an early to growth stage venture capital firm chaired by Gene Lockhart, the former CEO of MasterCard, led the equity round. Lockhart is joining the board of Behalf.
Victory Park Capital (VPC) provided a credit facility in addition to contributing to the equity round. Maverick Ventures as well as past investors Spark Capital and Sequoia Capital also participated.
Behalf will use the new funds to grow its team and increase the number and size
Equity corwdfunding platform Seedrs has announced a GBP10 million Series A fundraising round led by Woodford Patient Capital Trust plc (WPCT) and Augmentum Capital.
WPCT is the GBP800 million investment trust launched earlier this year by Woodford Investment Management. WPCT is managed by Neil Woodford, widely considered to be one of the UK's leading fund managers over the past 25 years. The trust invests mainly in early-stage and early-growth companies but also has exposure to some blue-chip companies.
Augmentum Capital is a venture capital firm founded in 2009 by two highly-experienced entrepreneurs and investors, Tim Levene and Richard Matthews.
Kensington Capital Partners’ Kensington Venture Fund has increased total investor commitments to the fund to CAD237 million. The Fund's third closing includes new commitments from institutional, family office and individual investors.
"We are pleased to see the increased investor attention to the Kensington Venture Fund," says Kensington Managing Director Rick Nathan. "As our portfolio takes shape, we can see the entire Canadian venture capital sector getting a strong boost from the Venture Capital Action Plan."
Launched in November 2014 with CAD160 million in initial investor commitments, the Fund received a lead investment from the Government of Canada's Venture Capital Action
Legg Mason is to acquire a majority equity interest in RARE Infrastructure (RARE) a specialist in global listed infrastructure investing headquartered in Sydney, Australia.
The firm, with offices in Sydney, Melbourne, London and Chicago, specialises in global listed infrastructure investments, managing USD7.6 billion for institutional and retail clients. The acquisition expands Legg Mason's offerings in equity liquid alternative investments, adding an experienced manager in a high-growth asset class.
The transaction is expected to be accretive to earnings on a GAAP and adjusted net income basis in the first year after closing, which is expected in the 4th calendar quarter of
NextStage AM has acquired a stake in La Compagnie du Catamaran, the controlling holding company of Fountaine Pajot, a global leader for sail and power cruising catamarans based in La Rochelle.
A pioneer in the market for sail cruising catamarans since 1983, Fountaine Pajot’s boatyard developed globally in this promising market and, as of 1998, led the way in the rapidly growing power catamaran segment thanks to its innovative profile.
For 40 years, the boatyard has designed, produced and marketed more than 2,500 catamarans and has launched more than 38 models to date. Last year (fiscal year ending August
FreemarketFX, the peer-to-peer currency exchange has closed its latest Angel investment round and has surpassed its fundraising target to raise a final investment sum of GBP670,000.
This brings the total raised by freemarketFX, in the last eight months, to just over GBP1.25 million. freemarketFX was publicly launched in January 2015.
The business was supported in its most recent fundraise efforts by VentureFounders, the UK based online equity investment platform. freemarketFX initially sought to raise GBP500,000 in this Enterprise Investment Scheme (EIS) eligible round, but has significantly exceeded this target.
The online currency exchange platform reduces currency exchange costs by
Featuring the latest data, this extract from the Preqin Quarterly Update: Private Equity, Q2 2015 looks at the rising amount of dry powder in the industry and up-to-date performance statistics.
With the fundraising market remaining robust and average final close sizes climbing, dry powder has continued to increase. The level of committed capital available to private equity fund managers for investment is standing at a new high, at USD1.3 trillion (Fig 1). This is an 18% increase since December 2014, with over half of the increase in dry powder attributable to private equity real estate and buyout funds.
Fig 2
Community Intervention Services, a portfolio company of HIG Growth Partners (HIG), has completed the acquisition of Futures Behavior Therapy Center, LLC (Futures).
CIS was established by HIG in partnership with behavioural healthcare executive Kevin Sheehan, to acquire, develop and operate a national network of specialised behavioural health treatment facilities and programs. Futures marks CIS's sixth acquisition and further expands the Company’s treatment capabilities for children with Autism Spectrum Disorders (“ASDs”) and other developmental disabilities.
Headquartered in Beverly, MA, Futures was founded in 2006 and has since grown into a leading clinic-based provider of treatment and education services for children with
Private equity firm GTCR’s portfolio company Capella Healthcare, is to be acquired by Medical Properties Trust, a Birmingham, Alabama based self-advised real estate investment trust, for USD900 million in cash.
The transaction is expected to close during the second half of 2015, following customary regulatory approvals.
GTCR formed Capella in partnership with Founder Dan Slipkovich in 2005 to acquire acute-care hospitals that serve rural and suburban markets. Today, Capella is a premier provider of healthcare services and one of the largest for-profit hospital companies in the U.S. The Company is dedicated to helping hospitals deliver a new level of healthcare
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
